Jeena Sikho Lifecare Limited has informed the Exchange about Investor Presentation
JSLL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Jeena Sikho Lifecare Limited has filed its Q1 FY26 Investor Presentation ahead of an investor meeting scheduled on August 18, 2025. Revenue from operations rose 74% year-on-year and 25% quarter-on-quarter to ₹174.29 crore, driven by broad-based growth across services and products. EBITDA jumped 220% YoY to ₹78.79 crore, with EBITDA margin expanding sharply from 25% in Q1FY25 to 45%, helped by operating leverage. Profit after tax grew 218% YoY to ₹51.31 crore, with EPS at ₹4.13. The company added 391 beds during the quarter (2,179 operational, 360 in pipeline) and recently migrated from NSE Emerge to the mainboards of NSE and BSE in August 2025, which should improve visibility and investor access.
Strong Q1 print with revenue, margins, and profits all showing significant YoY expansion is likely to be viewed positively by investors and may support the stock. The debt-free status, 71% average ROCE, mainboard migration, and continued bed capacity addition point to a healthy growth runway, though the recent rally (stock at ₹654 vs 52-week low of ₹241) leaves limited margin of safety.